TITLE

Wyeth, Schering-Plough scale down

PUB. DATE
June 2008
SOURCE
Pharmaceutical Representative;Jun2008, Vol. 38 Issue 6, p10
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers news briefs related to the pharmaceutical industry in New Jersey. Wyeth plans to reduce about 6% of its workforce by the end of 2008 as part of its strategic program called Project Impact. Schering-Plough Corp. aims to save $1.5 billion per year in its productivity transformation program. Fred Hassan, chairman and CEO of Schering-Plough, states that the company will not implement across-the-board cost-cutting and will avoid unwise short-term actions.
ACCESSION #
32429542

 

Related Articles

  • Hassan lays out Schering agenda.  // Medical Marketing & Media;Jun2003, Vol. 38 Issue 6, p16 

    Highlights Schering-Plough Chairman Fred Hassan's speech at the 2003 annual meeting. Hassan's statement that there are no quick fixes to the company's various legal and compliance problems; Hassan's rejection of speculation that he was looking for a merger partner.

  • TOP STORIES.  // MondayMorning;1/21/2008, Vol. 16 Issue 3, p1 

    This section offers news briefs on the pharmaceuticals industry. Schering-Plough Corp. Chief Executive Fred Hassan says the company stands by the effectiveness of its cholesterol drug Vytorin. GlaxoSmithKline Plc, AstraZeneca Plc and at least seven competitors were raided as part of a European...

  • MondayMorning for 2008 April 07.  // MondayMorning;4/ 7/2008, Vol. 16 Issue 14, p1 

    Monday, April 7, 2008 / Vol. 16 / No. 14 MondayMorning Weekly Online News Update for the Healthcare Industry Monday, April 7, 2008 / Vol. 16 / No. 14 ©2008 MedContent, Inc / All Rights Reserved TOP STORIES Schering-Plough Embarks on Massive Cost-Cutting Program. Schering-Plough Corp....

  • Fred Hassan. Strupp, Joe // njbiz;7/17/2006, Vol. 19 Issue 29, p15 

    The article profiles Fred Hassan, chairman and CEO of Schering-Plough. Hassan was the head of Pharmacia from 2001 to 2003 and lead the selling of the company to Pfizer for $60 billion. Hassan was acquired by Schering-Plough in 2003 during the time when the company was being repeatedly cited by...

  • Being Fred Hassan. Breitstein, Joanna // Pharmaceutical Executive;Oct2007, Vol. 27 Issue 10, p72 

    The article discusses how Fred Hassan, head of the drug manufacturer Schering-Plough Corp., displayed a strong sense of leadership in the midst of a troubled modern-day company. Hassan shares that his father being the first ambassador to India, he was able to learn about war, diplomacy and...

  • Is It Too Late to Save Schering? Simons, John // Fortune;9/15/2003, Vol. 148 Issue 5, p145 

    Profiles Fred Hassan and his role as chief executive at the pharmaceutical company Shering-Plough. His campaign to restore employee confidence; Consideration of Hassan's management style; Production of Claritin, the allergy medicine, by the company; Importance of communication in business;...

  • Fred Hassan.  // Nature Reviews Drug Discovery;Dec2005, Vol. 4 Issue 12, p952 

    An interview with Schering-Plough Corp. (SPC) chief executive officer Fred Hassan is presented. When asked on the aspects for SPC to be a new kind of healthcare company, he refers good sensing mechanisms and excellent execution. Hassan believes that in order for big pharmaceutical industry to...

  • What They're Saying….  // Pharmaceutical Executive;Nov2006, Vol. 26 Issue 11, p21 

    The article reports on the business condition of the pharmaceutical industry in the U.S. Fred Hassan, CEO of Schering Plough, talks on the stability of the company as compared to other pharmaceutical companies. Bristol-Myers Squibb is allegedly hunting for executives to lead the indented...

  • Hassan engineers a turnaround. Jarvis, Lisa // Chemical Market Reporter;10/31/2005, Vol. 268 Issue 15, p46 

    Focuses on the success of CEO Fred Hassan in turning Schering-Plough Corp. into financial stability in the U.S. Program initiated to set the company back on solid ground; Achievement in improving sales; Role in strengthening its portfolio products.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics